| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...870991C |
| P356 | DOI | 10.1371/JOURNAL.PONE.0070991 |
| P932 | PMC publication ID | 3737232 |
| P698 | PubMed publication ID | 23951061 |
| P5875 | ResearchGate publication ID | 255959463 |
| P2093 | author name string | Domenico Praticò | |
| Jin Chu | |||
| Jin-Guo Li | |||
| P2860 | cites work | 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease | Q36299503 |
| 5-Lipoxygenase: regulation of expression and enzyme activity | Q36852065 | ||
| Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease. | Q36974939 | ||
| 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease | Q37232572 | ||
| Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease | Q37441782 | ||
| Post-translational modifications of tau protein: implications for Alzheimer's disease. | Q37826875 | ||
| Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase | Q39689586 | ||
| 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early-onset and late-onset Alzheimer's disease | Q43670979 | ||
| Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease | Q45172855 | ||
| A randomized, comparative, multicentric clinical trial to assess the efficacy and safety of zileuton extended-release tablets with montelukast sodium tablets in patients suffering from chronic persistent asthma | Q46190704 | ||
| The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old. | Q48438144 | ||
| Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity | Q48983820 | ||
| Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease | Q24657243 | ||
| p39 activates cdk5 in neurons, and is associated with the actin cytoskeleton | Q28145210 | ||
| Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease | Q30540833 | ||
| 5-lipoxygenase as an endogenous modulator of amyloid β formation in vivo | Q34636148 | ||
| Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model involvement of γ-secretase | Q34805615 | ||
| Cdk5: One of the links between senile plaques and neurofibrillary tangles? | Q35116571 | ||
| Advances in therapy with antileukotriene drugs | Q36008377 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | e70991 | |
| P577 | publication date | 2013-08-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles | |
| P478 | volume | 8 |
| Q38980572 | A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice |
| Q51731158 | Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice. |
| Q37739453 | Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer's phenotype. |
| Q37184747 | GATA1-mediated transcriptional regulation of the γ-secretase activating protein increases Aβ formation in Down syndrome |
| Q35185115 | Homocysteine exacerbates β-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles |
| Q37678192 | Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. |
| Q54976720 | Learning Impairments, Memory Deficits, and Neuropathology in Aged Tau Transgenic Mice Are Dependent on Leukotrienes Biosynthesis: Role of the cdk5 Kinase Pathway. |
| Q48127496 | Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice |
| Q37576743 | Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses |
| Q64121987 | New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties |
| Q54979137 | Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase. |
| Q37678676 | Novel lipid signaling pathways in Alzheimer's disease pathogenesis |
| Q35929097 | Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy |
| Q35745694 | Regulation of gamma-secretase activating protein by the 5Lipoxygenase: in vitro and in vivo evidence |
| Q33949740 | Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3β of substituted quinolines. |
| Q35691073 | The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Δ13 Isoform Differs from That of Its Full Length Counterpart |
| Q89771694 | The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies |
| Q26795652 | The role of lipoxygenases in pathophysiology; new insights and future perspectives |
| Q34225004 | Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice |
Search more.